Trial Profile
An early diagnosis of asthma in young children by using non-invasive biomarkers of oxidative stress/airway inflammation.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Biomarker; Pharmacodynamics
- 22 Aug 2011 New trial record